These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 4637961

  • 1. The MOPP controversy.
    DiBiasio AG.
    Eye Ear Nose Throat Mon; 1972 Dec; 51(12):459-60. PubMed ID: 4637961
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA, Hum GJ, Sheehan WW, Ryden VM, Bateman JR.
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [Abstract] [Full Text] [Related]

  • 5. [Multiple drug treatment of Hodgkin's disease: the MOPP schedule].
    Singer Z, Dzieza-Lalowicz I, Kardaszewicz S, Rozek-Lesiak K.
    Nowotwory; 1978 May; 28(2):203-8. PubMed ID: 683884
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MOPP after two decades.
    Longo DL, Young RC, Duffey PL, Hubbard SM, DeVita VT.
    J Clin Oncol; 1987 Feb; 5(2):320-1. PubMed ID: 3806177
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MOPP dose intensity and survival: flawed analysis.
    Cohen MH.
    J Clin Oncol; 1990 Apr; 8(4):756-7. PubMed ID: 2313341
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P, Abate G, Fiore M, Di Finizio G, Frezza P, Scoppa G, Anania C, Coucourde F, Zarrilli D.
    J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy of acute leukemia and Hodgkin's disease.
    Frei E.
    JAMA; 1972 Nov 27; 222(9):1168. PubMed ID: 4678057
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dilemmas in the treatment of Hodgkin's disease.
    Somers R, Lutz-Honders M, Cleton FJ, van Dongen JA.
    Folia Med Neerl; 1971 Nov 27; 14(2):77-88. PubMed ID: 4934404
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.